Do you have an interest in safe medicines for children – as a parent, researcher or prescriber? If so, you are invited to participate in a stakeholder consultation launched by the European Commission. The aim is to gather real-life experiences and opinions on the Paediatric Regulation which came into force a decade ago and has three main objectives:
- to ensure high-quality research into the development of medicines for children
- to ensure that the majority of medicines used by children are specifically authorised for such use and so reduce the level of off-label use
- to ensure the availability of high-quality information about medicines used by children.
The consultation is open until 20 February 2017.
More information about medicines for children and to contribute to the consultation on the ec.europa.eu website.